<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zhps</journal-id><journal-title-group><journal-title xml:lang="ru">Журнал прикладной спектроскопии</journal-title><trans-title-group xml:lang="en"><trans-title>Zhurnal Prikladnoii Spektroskopii</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0514-7506</issn><publisher><publisher-name>B. I. Stepanov Institute of Physics of the National Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">zhps-848</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АННОТАЦИИ АНГЛОЯЗЫЧНЫХ СТАТЕЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ABSTRACTS ENGLISH-LANGUAGE ARTICLES</subject></subj-group></article-categories><title-group><article-title>Спектрофлуориметрический метод определения цефдинира по продуктам его разложения</article-title><trans-title-group xml:lang="en"><trans-title>Development and Validation of a Spectrofluorimetric Method for the Determination of Cefdinir Via Its Degradation Products</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Boltia</surname><given-names>S. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Boltia</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каир, 11562</p></bio><bio xml:lang="en"><p>Faculty of Pharmacy</p><p>ET-H562 Cairo, Egypt</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Algmaal</surname><given-names>S. E.</given-names></name><name name-style="western" xml:lang="en"><surname>Algmaal</surname><given-names>S. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каир, 11562</p></bio><bio xml:lang="en"><p>Faculty of Pharmacy</p><p>ET-H562 Cairo, Egypt</p></bio><email xlink:type="simple">shrouk.elgmaal@pharma.cu.edu.eg</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Mostafa</surname><given-names>N. M.</given-names></name><name name-style="western" xml:lang="en"><surname>Mostafa</surname><given-names>N. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каир, 11562</p></bio><bio xml:lang="en"><p>Faculty of Pharmacy</p><p>ET-H562 Cairo, Egypt</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>El Saharty</surname><given-names>Y. S.</given-names></name><name name-style="western" xml:lang="en"><surname>El Saharty</surname><given-names>Y. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каир, 11562</p></bio><bio xml:lang="en"><p>Faculty of Pharmacy</p><p>ET-H562 Cairo, Egypt</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Каирский университет</institution></aff><aff xml:lang="en"><institution>Analytical Chemistry Department</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>29</day><month>05</month><year>2021</year></pub-date><volume>88</volume><issue>2</issue><elocation-id>336(1)-336(9)</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Boltia S.A., Algmaal S.E., Mostafa N.M., El Saharty Y.S., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Boltia S.A., Algmaal S.E., Mostafa N.M., El Saharty Y.S.</copyright-holder><copyright-holder xml:lang="en">Boltia S.A., Algmaal S.E., Mostafa N.M., El Saharty Y.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://zhps.ejournal.by/jour/article/view/848">https://zhps.ejournal.by/jour/article/view/848</self-uri><abstract><p>Разработан и апробирован чувствительный и точный спектрофлуориметрический метод определения цефдинира (CEF) — цефалоспоринового препарата третьего поколения, основанный на обнаружении продуктов его разложения в реакциях с кислотой и щелочью. Лекарство определяли по продуктам его кислотно-индуцированной деградации при 408 нм и возбуждении на 292 нм и по его продуктам разложения, индуцированным щелочью, при 458 нм после возбуждения при 330 нм. Для продуктов деградации при воздействии кислоты и щелочи получена линейная зависимость в диапазонах 0.7-7.0 и 0.03-0.30 мкг/мл. Исследование путей разложения осуществлено с помощью ИК-спектроскопии и методики LC/MS/MS. Данный подход одобрен на Международной конференции по гармонизации, метод апробирован с высокой точностью определения CEF в нефасованных порошках и фармацевтических лекарственных формах. Результаты, полученные с применением спек-трофлуориметрического метода, согласуются с полученными методом HPLC.</p></abstract><trans-abstract xml:lang="en"><p>A sensitive and accurate stability-indicating spectrofluorimetric method was created and validated for the determination of Cefdinir (CEF), a third-generation cephalosporin drug, via its acid and alkali-induced degradation products. The drug was determined via its acid-induced degradation products at 408 nm using an excitation wavelength of 292 nm, and via its alkali-induced degradation products at 458 nm after excitation at 330 nm. Linearity was achieved in the ranges 0.7—7.0 and 0.03-0.30 µg/mL for the acid-induced and alkali-induced degradation products, respectively. The investigation of degradation pathways was achieved using IR and LC/MS/MS. The technique was also validated by the International Conference on Harmonization Guidelines. The proposed technique was effectively implemented with excellent accuracy and precision to determine CEF in bulk powder and pharmaceutical dosage forms. The final results obtained by the application of the spectrofluorimetric method excellently agreed with the reported HPLC method.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>цефдинир</kwd><kwd>индикатор стабильности</kwd><kwd>спектрофлуориметрический метод</kwd><kwd>це-фалоспорины</kwd><kwd>деградация</kwd><kwd>валидация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Cefdinir</kwd><kwd>stability indicating</kwd><kwd>spectrofluorimetric method</kwd><kwd>cephalosporins</kwd><kwd>degradation</kwd><kwd>validation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">D. R. Guay, Clin. Terap, 24, No. 4, 473-489 (2002).</mixed-citation><mixed-citation xml:lang="en">D. R. Guay, Clin. Terap, 24, No. 4, 473-489 (2002).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">O. Abdel-Aziz, M. Farouk, R. Nagi, L. Abdel-Fattah, J. Appl. Pharm. Sci., 4, No. 7, 129 (2014).</mixed-citation><mixed-citation xml:lang="en">O. Abdel-Aziz, M. Farouk, R. Nagi, L. Abdel-Fattah, J. Appl. Pharm. Sci., 4, No. 7, 129 (2014).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Erhan Bas, S. Ozdemir, M. G. £aglayan, i. Murat, F. O. Palabiyik, Turk. J. Pharm. Sci, 10, No. 3, 321-328 (2013).</mixed-citation><mixed-citation xml:lang="en">Erhan Bas, S. Ozdemir, M. G. £aglayan, i. Murat, F. O. Palabiyik, Turk. J. Pharm. Sci, 10, No. 3, 321-328 (2013).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">M. El-Ashry, Am. J. Pharm. Res, 4, No. 4, 239-258 (2014).</mixed-citation><mixed-citation xml:lang="en">M. El-Ashry, Am. J. Pharm. Res, 4, No. 4, 239-258 (2014).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">A. A. Elbashir, A. A. Ahmed, S. M. Ali Ahmed, H. Y. Aboul-Enein, Appl. Spectrosc. Rev., 47, No. 3, 219-232 (2012).</mixed-citation><mixed-citation xml:lang="en">A. A. Elbashir, A. A. Ahmed, S. M. Ali Ahmed, H. Y. Aboul-Enein, Appl. Spectrosc. Rev., 47, No. 3, 219-232 (2012).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">F. Ibrahim, M. Wahba, G. Magdy, Spectrochim. Acta A: Mol. Biomol. Spectrosc., 188, 525-536 (2018).</mixed-citation><mixed-citation xml:lang="en">F. Ibrahim, M. Wahba, G. Magdy, Spectrochim. Acta A: Mol. Biomol. Spectrosc., 188, 525-536 (2018).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">B. K. Singh, D. V. Parwate, S. Srivastava, S. Shukla, Qum. Nova, 33, No. 7, 1471-1475 (2010).</mixed-citation><mixed-citation xml:lang="en">B. K. Singh, D. V. Parwate, S. Srivastava, S. Shukla, Qum. Nova, 33, No. 7, 1471-1475 (2010).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Z.-j. Chen, J. Zhang, J.-C. Yu, G.-Y. Cao, X.-J. Wu, Y.-G. Shi, J. Chromatogr. B, 834, No. 1-2, 163-169 (2006)</mixed-citation><mixed-citation xml:lang="en">Z.-j. Chen, J. Zhang, J.-C. Yu, G.-Y. Cao, X.-J. Wu, Y.-G. Shi, J. Chromatogr. B, 834, No. 1-2, 163-169 (2006)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">P. Hamrapurkar, P. Patil, M. Phale, M. Gandhi, S. Pawar, Pharm. Methods, 2, No. 1, 15-20 (2011).</mixed-citation><mixed-citation xml:lang="en">P. Hamrapurkar, P. Patil, M. Phale, M. Gandhi, S. Pawar, Pharm. Methods, 2, No. 1, 15-20 (2011).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">H. Hashem, A. A. Gouda, W. Hassan, J. Liq. Chromatogr. Relat. Technol., 35, No. 12, 1638-1648 (2012).</mixed-citation><mixed-citation xml:lang="en">H. Hashem, A. A. Gouda, W. Hassan, J. Liq. Chromatogr. Relat. Technol., 35, No. 12, 1638-1648 (2012).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">S. R. Narala, K. Saraswathi, J. Pharm. Sci. Res., 3, No. 1, 1002 (2011).</mixed-citation><mixed-citation xml:lang="en">S. R. Narala, K. Saraswathi, J. Pharm. Sci. Res., 3, No. 1, 1002 (2011).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Y. Okamoto, K. Itoh, Y. Namiki, J. Matsushita, M. Fujioka, T. Yasuda, J. Pharm. Biomed. Anal, 14, No. 6, 739-748 (1996).</mixed-citation><mixed-citation xml:lang="en">Y. Okamoto, K. Itoh, Y. Namiki, J. Matsushita, M. Fujioka, T. Yasuda, J. Pharm. Biomed. Anal, 14, No. 6, 739-748 (1996).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">G. M. Hadad, S. Emara, W. M. Mahmoud, Chromatographia, 70, No. 11-12, 1593 (2009).</mixed-citation><mixed-citation xml:lang="en">G. M. Hadad, S. Emara, W. M. Mahmoud, Chromatographia, 70, No. 11-12, 1593 (2009).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">U. Mashelkar, S. D. Renapurkar, Int. J. Chem. Technol. Res, 2, 114-121 (2010).</mixed-citation><mixed-citation xml:lang="en">U. Mashelkar, S. D. Renapurkar, Int. J. Chem. Technol. Res, 2, 114-121 (2010).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">R. Jain, K. Radhapyari, N. Jadon, J. Electrochem. Soc., 154, No. 11, 199-204 (2007)</mixed-citation><mixed-citation xml:lang="en">R. Jain, K. Radhapyari, N. Jadon, J. Electrochem. Soc., 154, No. 11, 199-204 (2007)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">A. Abdollahi, A. B. Tabrizi, Pharm. Sci., 22, No. 1, 28 (2016).</mixed-citation><mixed-citation xml:lang="en">A. Abdollahi, A. B. Tabrizi, Pharm. Sci., 22, No. 1, 28 (2016).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">A. Suganthi, S. Shrikumar, M. B. Pattesseril, M. Umamaheswari, T. Ravi, Indian J. Pharm. Sci, 66, No. 5, 689 (2004).</mixed-citation><mixed-citation xml:lang="en">A. Suganthi, S. Shrikumar, M. B. Pattesseril, M. Umamaheswari, T. Ravi, Indian J. Pharm. Sci, 66, No. 5, 689 (2004).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
